BioXcel Therapeutics, Inc.
Total Trades
63
Buys
0
Sells
33
Largest Trade
N/A
Insiders
7
Institutional Funds
31
Inst. Value
$1M+
Activist Filings
20
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Wiley Matthew T. | Chief Commercial O… | GRANT | N/A | 21K | — | Oct 4, 2024 |
| Wiley Matthew T. | Chief Commercial O… | SELL | $1K–$15K | 6K | $0.55 | Oct 4, 2024 |
| Rodriguez Javier | See Remarks | GRANT | N/A | 21K | — | Oct 4, 2024 |
| Rodriguez Javier | See Remarks | SELL | $1K–$15K | 7K | $0.55 | Oct 4, 2024 |
| Yocca Frank | Chief Scientific O… | SELL | $1K–$15K | 7K | $0.55 | Oct 4, 2024 |
| Yocca Frank | Chief Scientific O… | GRANT | N/A | 21K | — | Oct 4, 2024 |
| Steinhart Richard I | CFO | SELL | $1K–$15K | 7K | $0.55 | Oct 4, 2024 |
| Steinhart Richard I | CFO | GRANT | N/A | 21K | — | Oct 4, 2024 |
| O'Neill Vincent | See Remarks | SELL | $1K–$15K | 6K | $0.55 | Oct 4, 2024 |
| O'Neill Vincent | See Remarks | GRANT | N/A | 21K | — | Oct 4, 2024 |
| Yocca Frank | Chief Scientific O… | EXERCISE | N/A | 1K | — | Jun 19, 2024 |
| Yocca Frank | Chief Scientific O… | SELL | <$1K | 372 | $1.28 | Jun 19, 2024 |
| Wiley Matthew T. | Chief Commercial O… | SELL | <$1K | 244 | $1.26 | Jun 19, 2024 |
| Wiley Matthew T. | Chief Commercial O… | EXERCISE | N/A | 750 | — | Jun 19, 2024 |
| Steinhart Richard I | CFO | EXERCISE | N/A | 1K | — | Jun 19, 2024 |
| Steinhart Richard I | CFO | SELL | <$1K | 372 | $1.26 | Jun 19, 2024 |
| Rodriguez Javier | See Remarks | SELL | <$1K | 361 | $1.26 | Jun 19, 2024 |
| Rodriguez Javier | See Remarks | EXERCISE | N/A | 1K | — | Jun 19, 2024 |
| O'Neill Vincent | See Remarks | SELL | <$1K | 155 | $1.28 | Jun 19, 2024 |
| O'Neill Vincent | See Remarks | EXERCISE | N/A | 521 | — | Jun 19, 2024 |
| Mehta Vimal | CEO and President | SELL | $1K–$15K | 2K | $1.28 | Jun 19, 2024 |
| Mehta Vimal | CEO and President | EXERCISE | N/A | 6K | — | Jun 19, 2024 |
| Mehta Vimal | CEO and President | SELL | $100K–$500K | 1.4M | $0.28 | Jun 7, 2024 |
| O'Neill Vincent | See Remarks | SELL | <$1K | 165 | $2.62 | Apr 8, 2024 |
| O'Neill Vincent | See Remarks | EXERCISE | N/A | 3K | — | Apr 8, 2024 |
| Mehta Vimal | CEO and President | EXERCISE | N/A | 17K | — | Apr 8, 2024 |
| Mehta Vimal | CEO and President | SELL | $1K–$15K | 5K | $2.62 | Apr 8, 2024 |
| Steinhart Richard I | CFO | EXERCISE | N/A | 3K | — | Apr 8, 2024 |
| Steinhart Richard I | CFO | SELL | $1K–$15K | 1K | $2.63 | Apr 8, 2024 |
| Wiley Matthew T. | CHIEF COMMERCIAL O… | SELL | $1K–$15K | 1K | $2.64 | Apr 8, 2024 |
| Wiley Matthew T. | CHIEF COMMERCIAL O… | EXERCISE | N/A | 3K | — | Apr 8, 2024 |
| Rodriguez Javier | See Remarks | EXERCISE | N/A | 3K | — | Apr 8, 2024 |
| Rodriguez Javier | See Remarks | SELL | $1K–$15K | 1K | $2.64 | Apr 8, 2024 |
| Yocca Frank | Chief Scientific O… | EXERCISE | N/A | 3K | — | Apr 8, 2024 |
| Yocca Frank | Chief Scientific O… | SELL | $1K–$15K | 1K | $2.63 | Apr 8, 2024 |
| Mehta Vimal | CEO and President | EXERCISE | $15K–$50K | 63K | $0.39 | Jun 16, 2023 |
| Mehta Vimal | CEO and President | SELL | $1M+ | 60K | $20.86 | Jun 16, 2023 |
| Mehta Vimal | CEO and President | SELL | $100K–$500K | 7K | $25.79 | May 24, 2023 |
| Steinhart Richard I | CFO | SELL | $100K–$500K | 5K | $27.17 | May 17, 2023 |
| Steinhart Richard I | CFO | EXERCISE | N/A | 5K | — | May 17, 2023 |
| Rodriguez Javier | See Remarks | EXERCISE | N/A | 5K | — | May 17, 2023 |
| Rodriguez Javier | See Remarks | SELL | $15K–$50K | 2K | $27.32 | May 17, 2023 |
| Nandabalan Krishnan | Director | EXERCISE | $15K–$50K | 60K | $0.41 | Apr 10, 2023 |
| Nandabalan Krishnan | Director | SELL | $1M+ | 60K | $17.32 | Apr 10, 2023 |
| Mehta Vimal | CEO and President | EXERCISE | $15K–$50K | 60K | $0.41 | Mar 22, 2023 |
| Mehta Vimal | CEO and President | SELL | $1M+ | 65K | $18.97 | Mar 22, 2023 |
| Steinhart Richard I | CFO | EXERCISE | N/A | 2K | — | Mar 16, 2023 |
| Steinhart Richard I | CFO | SELL | $15K–$50K | 2K | $19.50 | Mar 16, 2023 |
| Yocca Frank | Chief Scientific O… | SELL | $15K–$50K | 985 | $19.69 | Mar 16, 2023 |
| Yocca Frank | Chief Scientific O… | EXERCISE | N/A | 2K | — | Mar 16, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 31 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 207K | $100K–$500K | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 167K | $100K–$500K | SH |
| JANE STREET GROUP, LLC | 127K | $100K–$500K | SH |
| GSA CAPITAL PARTNERS LLP | 120K | $100K–$500K | SH |
| BlackRock, Inc. | 84K | $100K–$500K | SH |
| STATE STREET CORP | 63K | $100K–$500K | SH |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 3K | $50K–$100K | SH |
| Man Group plc | 57K | $50K–$100K | SH |
| HighTower Advisors, LLC | 41K | $50K–$100K | SH |
| DIVERSIFY WEALTH MANAGEMENT, LLC | 15K | $15K–$50K | SH |
| HRT FINANCIAL LP | 18K | $15K–$50K | SH |
| Portfolio Strategies, Inc. | 12K | $15K–$50K | SH |
| CITIGROUP INC | 12K | $15K–$50K | SH |
| IFP Advisors, Inc | 4K | $1K–$15K | SH |
| GROUP ONE TRADING LLC | 3K | $1K–$15K | SH |
| Caitong International Asset Management Co., Ltd | 2K | $1K–$15K | SH |
| Caitong International Asset Management Co., Ltd | 2K | $1K–$15K | SH |
| MORGAN STANLEY | 1K | $1K–$15K | SH |
| NewEdge Advisors, LLC | 1K | $1K–$15K | SH |
| Caitong International Asset Management Co., Ltd | 446 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Integrated Core Strategies (US) LLC
SC 13G/A · Feb 9, 2026
8.4%
1.8M shares
Integrated Core Strategies (US) LLC
SC 13G · Oct 1, 2025
5.2%
1.0M shares
SC 13G/A · May 15, 2025
0.8%
51K shares
SC 13G/A · May 15, 2025
5.0%
288K shares
SC 13G · Feb 14, 2025
10.0%
5.0M shares
SC 13G · Dec 19, 2024
1.6%
823K shares
SC 13G · Dec 18, 2024
5.2%
2.7M shares
SC 13G/A · Sep 10, 2024
2.6%
1.1M shares
SC 13D/A · Jun 7, 2024
20.5%
7.7M shares
SC 13G/A · Oct 19, 2023
30.1%
8.9M shares
SC 13G/A · Oct 13, 2023
9.2%
2.7M shares
SC 13G/A · Oct 10, 2023
9.2%
2.7M shares
SC 13D · Sep 28, 2023
29.2%
8.5M shares
SC 13G/A · Apr 4, 2023
29.5%
8.5M shares
SC 13G/A · Feb 14, 2023
30.5%
8.5M shares
AllianceBernstein L.P. 13-4064930
SC 13G/A · Feb 14, 2023
0.1%
24K shares
SC 13G · Feb 3, 2023
5.2%
1.5M shares
SC 13G · Feb 2, 2023
5.5%
1.5M shares
SC 13G/A · Feb 14, 2022
30.5%
8.5M shares
AllianceBernstein L.P. 13-4064930
SC 13G · Feb 14, 2022
5.4%
1.5M shares